【摘 要】
：
In this study,we developed a systemic PD model in middle-aged cynomolgus monkeys using individualized low-dose MPTP,to explore effective indicators for the early prediction of clinical outcomes.MPTP was not stopped until the animals showed typical PD moto
【机 构】
：
Department of Neurobiology, Beijing Institute of Geriatrics,Xuanwu Hospital of Capital Medical Unive
论文部分内容阅读
In this study,we developed a systemic PD model in middle-aged cynomolgus monkeys using individualized low-dose MPTP,to explore effective indicators for the early prediction of clinical outcomes.MPTP was not stopped until the animals showed typical PD motor symptoms on days 10 to 13 after MPTP administration when the Kurlan score reached 10;this abrogated the differences in individual susceptibility to MPTP.The clinical symptoms persisted,peaking on days 3 to 12 after MPTP withdrawal (rapid progress stage),and then the Kurlan score plateaued.A Kurlan score at the end of the rapid progress stage ＞15 reflected stable or slowly-progressive PD,while a score ＜15 indicated spontaneous recovery.The entire clinical evolution and outcome of the systemic PD model was characterized in this study,thus providing options for therapeutic and translational research.
其他文献
Alzheimer\'s disease (AD) is the most common form of dementia among the elderly,characterized by amyloid plaques,neurofibrillary tangles,and neuroinflammation in the brain,as well as impaired cognitive behaviors.A sex difference in the prevalence of AD
Drosophila dEAAT2,a member of the excitatory amino-acid transporter (EAAT) family,has been described as mediating the high-affinity transport of taurine,which is a free amino-acid abundant in both insects and mammals.However,the role of taurine and its tr
Neurostimulation remarkably alleviates the symptoms in a variety of brain disorders by modulating the brain-wide network.However,how brain-wide effects on the direct and indirect pathways evoked by focal neurostimulation elicit therapeutic effects in an i
Fluoxetine,an anti-depressant drug,has recently been shown to provide neuroprotection in central nervous system injury,but its roles in subarachnoid hemorrhage (SAH) remain unclear.In this study,we aimed to evaluate whether fluoxetine attenuates early bra
In this study,we used functional magnetic resonance imaging (fMRI) to investigate longitudinal changes in brain activation during a verbal working memory (VWM) task performed by patients who had experienced a transient ischemic attack (TIA).Twenty-five fi
With the development of modern international medicine,the subject of disorders of consciousness (DOCs)has begun to be raised in mainland China.Much progress has been made to date in several specialties related to the management of chronic DOC patients in
The Autism Spectrum Rating Scale (ASRS) and the Social Responsiveness Scale (SRS) have been widely used for screening autism spectrum disorder (ASD) in the general population during epidemiological studies,but studies of individuals with intellectual disa
Autism spectrum disorder (ASD) encompasses a complex set of developmental neurological disorders,characterized by deficits in social communication and excessive repetitive behaviors.In recent years,ASD is increasingly being considered as a disease of the
Dear Editor,rnBody protection compound (BPC) 157 is a stable gastric pentadecapeptide.Predrag Sikiric\'s team has carried out many investigations of its cytoprotective effects in different organs and tissues [1,2].Their evidence indicates that BPC157 ha
Treatment for disorders of consciousness (DOCs) is still a Gordian knot.Evidence-based guidelines on the treatment of DOC patients are not currently available,while neuromodulation techniques are seen as a potential treatment.Multiple neuromodulation ther